| OPACX | SPAYX | OPACX / SPAYX | |
| Total Expense Ratio | 1.59 | 0.48 | 331% |
| Annual Report Gross Expense Ratio | 1.59 | 0.59 | 269% |
| Fund Existence | 31 years | 11 years | - |
| Gain YTD | 1.624 | 0.545 | 298% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 669M | 139M | 481% |
| Annual Yield % from dividends | 3.70 | 2.41 | 154% |
| Returns for 1 year | 6.22 | 5.04 | 123% |
| Returns for 3 years | 8.97 | 9.89 | 91% |
| Returns for 5 years | 0.66 | 2.94 | 22% |
| Returns for 10 years | 25.99 | 13.74 | 189% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IHE | 90.02 | 1.03 | +1.16% |
| iShares US Pharmaceuticals ETF | |||
| RINF | 32.76 | -0.02 | -0.07% |
| ProShares Inflation Expectations | |||
| UPSG | 17.26 | -0.02 | -0.13% |
| Leverage Shares 2X Long UPS Daily ETF | |||
| CHGX | 33.39 | -0.12 | -0.37% |
| EA SERIES TRUST STANCE SUSTAINABLE BETA ETF | |||
| ITOT | 165.05 | -1.21 | -0.73% |
| iShares Core S&P Total US Stock Mkt ETF | |||